دورية أكاديمية
أعرض في EDS

Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression.

التفاصيل البيبلوغرافية
العنوان: Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression.
المؤلفون: Bakhsh T; Department of Biology, Faculty of Science, Jeddah University, Jeddah 21589, Saudi Arabia., Alhazmi S; Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Alburae NA; Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Farsi A; Department of Surgry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Alzahrani F; King Fahd Medical Research Center, Embryonic Stem Cells Unit, Department of Biochemistry, Faculty of Science, King AbdulAziz University, Jeddah 21589, Saudi Arabia.; Centre of Artificial Intelligence in Precision Medicines, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Choudhry H; Centre of Artificial Intelligence in Precision Medicines, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia., Bahieldin A; Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2022 Apr 27; Vol. 23 (9). Date of Electronic Publication: 2022 Apr 27.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Colorectal Neoplasms*/diagnosis , Colorectal Neoplasms*/genetics , Exosomes*/genetics , Exosomes*/pathology , Extracellular Vesicles*/pathology , MicroRNAs*/genetics, Biomarkers, Tumor/genetics ; Female ; Humans ; Male ; Tumor Microenvironment/genetics
مستخلص: Colorectal cancer (CRC) is the third most common type of cancer worldwide amongst males and females. CRC treatment is multidisciplinary, often including surgery, chemotherapy, and radiotherapy. Early diagnosis of CRC can lead to treatment initiation at an earlier stage. Blood biomarkers are currently used to detect CRC, but because of their low sensitivity and specificity, they are considered inadequate diagnostic tools and are used mainly for following up patients for recurrence. It is necessary to detect novel, noninvasive, specific, and sensitive biomarkers for the screening and diagnosis of CRC at earlier stages. The tumor microenvironment (TME) has an essential role in tumorigenesis; for example, extracellular vesicles (EVs) such as exosomes can play a crucial role in communication between cancer cells and different components of TME, thereby inducing tumor progression. The importance of miRNAs that are sorted into exosomes has recently attracted scientists' attention. Some unique sequences of miRNAs are favorably packaged into exosomes, and it has been illustrated that particular miRNAs can be directed into exosomes by special mechanisms that occur inside the cells. This review illustrates and discusses the sorted and transported exosomal miRNAs in the CRC microenvironment and their impact on CRC progression as well as their potential use as biomarkers.
References: World J Gastrointest Oncol. 2020 Apr 15;12(4):492-502. (PMID: 32368326)
PLoS One. 2014 Apr 04;9(4):e92921. (PMID: 24705249)
PLoS One. 2012;7(9):e44398. (PMID: 22970209)
PLoS One. 2020 Feb 24;15(2):e0229309. (PMID: 32092088)
Pol J Pathol. 2016 Jun;67(2):156-62. (PMID: 27543871)
Cell Rep. 2016 Oct 11;17(3):799-808. (PMID: 27732855)
Food Funct. 2019 Nov 1;10(11):7523-7532. (PMID: 31674611)
J Cell Biochem. 2014 May;115(5):987-95. (PMID: 24357456)
J Oncol. 2019 Oct 13;2019:8585276. (PMID: 31737071)
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4212-4223. (PMID: 32373957)
Int J Mol Sci. 2019 Sep 21;20(19):. (PMID: 31546654)
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):274-282. (PMID: 29852194)
Yonsei Med J. 2017 Sep;58(5):918-924. (PMID: 28792134)
Mol Cancer. 2020 Feb 27;19(1):43. (PMID: 32106859)
PLoS One. 2014 Nov 24;9(11):e113116. (PMID: 25420022)
Contemp Oncol (Pozn). 2014;18(1):1-6. (PMID: 24876814)
Nat Commun. 2018 Feb 22;9(1):771. (PMID: 29472616)
Front Oncol. 2020 Mar 13;10:294. (PMID: 32231999)
Cell. 2011 Mar 4;144(5):646-74. (PMID: 21376230)
Gut. 2017 Apr;66(4):654-665. (PMID: 26701878)
Cancer Epidemiol. 2015 Oct;39(5):734-44. (PMID: 26277328)
Cancer Res. 2014 Oct 15;74(20):5758-71. (PMID: 25261234)
BMC Genomics. 2012 Aug 01;13:357. (PMID: 22849433)
Nat Rev Cancer. 2004 Nov;4(11):891-9. (PMID: 15516961)
Hum Pathol. 2012 Aug;43(8):1157-68. (PMID: 22658275)
Mutagenesis. 2020 Jul 11;35(3):243-260. (PMID: 31784760)
Cancer Genomics Proteomics. 2006 Oct;3(5):317-324. (PMID: 18172508)
Int J Cancer. 2014 Jul 15;135(2):253-63. (PMID: 24122334)
Elife. 2015 Jul 01;4:e07197. (PMID: 26132860)
J Hematol Oncol. 2020 Oct 15;13(1):136. (PMID: 33059744)
Cancer Sci. 2017 Mar;108(3):390-397. (PMID: 28032929)
BMC Genomics. 2013 May 10;14:319. (PMID: 23663360)
Signal Transduct Target Ther. 2020 Aug 5;5(1):145. (PMID: 32759948)
Stem Cell Res Ther. 2019 Aug 23;10(1):263. (PMID: 31443679)
Onco Targets Ther. 2019 Aug 22;12:6865-6873. (PMID: 31686843)
Medicine (Baltimore). 2020 Feb;99(9):e19265. (PMID: 32118734)
Oncotarget. 2017 Mar 7;8(10):17081-17091. (PMID: 28177881)
J Biol Chem. 2010 Jun 4;285(23):17442-52. (PMID: 20353945)
BMC Genomics. 2018 Feb 14;19(1):146. (PMID: 29444662)
Br J Cancer. 2015 Jul 14;113(2):275-81. (PMID: 26057451)
Cancer Lett. 2020 Apr 28;476:13-22. (PMID: 32044357)
FEBS Lett. 2015 Jun 4;589(13):1391-8. (PMID: 25937124)
Biomark Insights. 2006;2:113-121. (PMID: 18079988)
Int J Biol Sci. 2019 Jan 6;15(1):1-11. (PMID: 30662342)
Int J Biol Sci. 2021 Jan 1;17(1):163-177. (PMID: 33390841)
Cancer Res. 2011 Nov 15;71(22):6921-5. (PMID: 22084445)
Cell Rep. 2014 Sep 11;8(5):1432-46. (PMID: 25159140)
Nat Commun. 2013;4:2980. (PMID: 24356509)
Future Sci OA. 2020 Feb 26;6(4):FSO465. (PMID: 32257377)
Cell Death Dis. 2016 Jul 28;7(7):e2312. (PMID: 27468688)
Integr Cancer Ther. 2018 Dec;17(4):1235-1246. (PMID: 29986606)
Cells. 2019 Jul 15;8(7):. (PMID: 31311206)
Int J Urol. 2020 Nov;27(11):1039-1049. (PMID: 32794300)
Oncogene. 2009 Nov 19;28(46):4065-74. (PMID: 19734943)
Am J Transl Res. 2019 Jul 15;11(7):4516-4523. (PMID: 31396355)
Nature. 2009 Oct 22;461(7267):1071-8. (PMID: 19847258)
Nat Commun. 2018 Feb 26;9(1):831. (PMID: 29483512)
Prog Mol Biol Transl Sci. 2017;146:47-94. (PMID: 28253991)
Cancers (Basel). 2020 Feb 17;12(2):. (PMID: 32079286)
Mol Ther Nucleic Acids. 2012 Feb 07;1:e10. (PMID: 23344721)
Elife. 2016 Aug 25;5:. (PMID: 27559612)
J Exp Clin Cancer Res. 2020 Apr 16;39(1):67. (PMID: 32299469)
Cancers (Basel). 2019 Jul 04;11(7):. (PMID: 31277414)
Int J Mol Sci. 2016 Feb 06;17(2):170. (PMID: 26861301)
World J Gastrointest Oncol. 2015 Dec 15;7(12):422-33. (PMID: 26690833)
Oncol Lett. 2021 Jun;21(6):481. (PMID: 33968197)
Br J Cancer. 2014 Oct 14;111(8):1572-80. (PMID: 25117811)
Int J Cancer. 2017 Jul 15;141(2):220-230. (PMID: 28240776)
Cell Mol Life Sci. 2018 Jan;75(2):193-208. (PMID: 28733901)
Clin Cancer Res. 2017 May 15;23(10):2391-2399. (PMID: 28143873)
Ann Saudi Med. 2015 May-Jun;35(3):189-95. (PMID: 26409792)
Nat Rev Cancer. 2013 Oct;13(10):714-26. (PMID: 24060863)
Nat Rev Immunol. 2020 Apr;20(4):209-215. (PMID: 31965064)
Cancer Manag Res. 2020 May 12;12:3363-3369. (PMID: 32494200)
Int J Cancer. 2020 Feb 15;146(4):1164-1173. (PMID: 31304978)
Clin Epigenetics. 2018 Apr 23;10:59. (PMID: 29713393)
Mol Cancer. 2019 Mar 19;18(1):43. (PMID: 30890168)
Gastroenterol Clin North Am. 2016 Sep;45(3):459-76. (PMID: 27546843)
Cell Physiol Biochem. 2017;44(5):1741-1748. (PMID: 29216623)
Med J Islam Repub Iran. 2016 May 09;30:366. (PMID: 27493910)
Signal Transduct Target Ther. 2020 Oct 19;5(1):242. (PMID: 33077737)
J Biol Chem. 2013 Apr 12;288(15):10849-59. (PMID: 23439645)
Cancer Biomark. 2018 Feb 6;21(2):261-267. (PMID: 29171985)
Kaohsiung J Med Sci. 2018 Sep;34(9):479-486. (PMID: 30173777)
Open Biol. 2019 Jan 31;9(1):180212. (PMID: 30958116)
Int J Mol Sci. 2020 Sep 04;21(18):. (PMID: 32899898)
Int J Mol Sci. 2018 Sep 17;19(9):. (PMID: 30227605)
Cell Rep. 2016 May 3;15(5):978-987. (PMID: 27117408)
Aliment Pharmacol Ther. 2012 Nov;36(10):929-40. (PMID: 23035890)
Int J Mol Sci. 2020 Nov 12;21(22):. (PMID: 33198080)
J Gastrointest Oncol. 2011 Dec;2(4):215-22. (PMID: 22811855)
Oncotarget. 2017 Feb 28;8(9):15252-15266. (PMID: 28146434)
PLoS One. 2017 Oct 5;12(10):e0185992. (PMID: 28982131)
Int J Mol Sci. 2020 Feb 19;21(4):. (PMID: 32092975)
Dis Model Mech. 2017 Mar 1;10(3):197-214. (PMID: 28250048)
Front Genet. 2019 Oct 08;10:933. (PMID: 31649721)
Cancer Gene Ther. 2017 Feb;24(2):48-56. (PMID: 27982021)
Pharmazie. 2017 Feb 1;72(2):107-112. (PMID: 29441863)
Int J Mol Med. 2021 Jun;47(6):. (PMID: 33907829)
Oncotarget. 2014 Dec 15;5(23):12083-96. (PMID: 25301729)
Nat Commun. 2017 Feb 17;8:14448. (PMID: 28211508)
Stem Cells Int. 2018 Aug 27;2018:8058979. (PMID: 30224923)
Mol Med Rep. 2016 Jan;13(1):273-80. (PMID: 26573378)
J Biol Chem. 2012 May 4;287(19):15874-85. (PMID: 22396543)
Signal Transduct Target Ther. 2021 Mar 8;6(1):109. (PMID: 33678805)
Elife. 2019 Aug 22;8:. (PMID: 31436530)
Hepatology. 2015 Apr;61(4):1284-94. (PMID: 25503676)
Int J Clin Exp Pathol. 2017 Sep 01;10(9):9509-9514. (PMID: 31966826)
Cell Death Dis. 2018 Oct 10;9(10):1037. (PMID: 30305607)
Oncotarget. 2016 Jun 14;7(24):35789-35802. (PMID: 27119506)
Annu Rev Med. 2015;66:129-43. (PMID: 25423595)
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8. (PMID: 18663219)
J Clin Invest. 2020 Jan 2;130(1):404-421. (PMID: 31593555)
J Exp Clin Cancer Res. 2015 Oct 06;34:111. (PMID: 26445347)
Front Oncol. 2020 Apr 07;10:472. (PMID: 32318350)
PLoS One. 2016 Apr 21;11(4):e0154134. (PMID: 27101102)
CA Cancer J Clin. 2008 May-Jun;58(3):130-60. (PMID: 18322143)
RNA Biol. 2019 Jun;16(6):770-784. (PMID: 30806147)
Gene. 2020 May 5;737:144481. (PMID: 32070749)
Nat Commun. 2011;2:282. (PMID: 21505438)
Cancer Epidemiol. 2012 Feb;36(1):e61-7. (PMID: 22018950)
Oncotarget. 2017 Apr 18;8(16):27393-27400. (PMID: 28404964)
فهرسة مساهمة: Keywords: biomarkers; colorectal cancer; exosomes; extracellular vesicles; miRNAs; tumor microenvironment
المشرفين على المادة: 0 (Biomarkers, Tumor)
0 (MicroRNAs)
تواريخ الأحداث: Date Created: 20220514 Date Completed: 20220517 Latest Revision: 20220716
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9103063
DOI: 10.3390/ijms23094855
PMID: 35563246
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms23094855